4576 — D.Western Therapeutics Institute Income Statement
0.000.00%
Last trade - 00:00- ¥6bn
- ¥5bn
- ¥472m
Annual income statement for D.Western Therapeutics Institute, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 414 | 448 | 428 | 472 | 388 |
| Cost of Revenue | |||||
| Gross Profit | 394 | 421 | 392 | 425 | 349 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 586 | 898 | 1,257 | 1,745 | 1,007 |
| Operating Profit | -172 | -450 | -829 | -1,273 | -620 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -160 | -440 | -827 | -1,289 | -630 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -161 | -442 | -828 | -1,290 | -632 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -149 | -430 | -812 | -1,290 | -632 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -149 | -430 | -812 | -1,290 | -632 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.08 | -11.3 | -24.9 | -35.6 | -13.2 |
| Dividends per Share |